Published in Ann Thorac Surg on January 15, 2012
Treatment options in patients with chylothorax. Dtsch Arztebl Int (2013) 1.15
Chylothorax after esophagectomy for cancer: impact of the surgical approach and neoadjuvant treatment: systematic review and institutional analysis. Surg Endosc (2013) 0.94
A high body mass index in esophageal cancer patients is not associated with adverse outcomes following esophagectomy. J Cancer Res Clin Oncol (2014) 0.83
Lymphoscintigraphy combined with single-photon emission computed tomography-computed tomography (SPECT-CT): A very effective imaging approach for identification of the site of leak in postoperative chylothorax. Indian J Nucl Med (2015) 0.79
Managing complications I: leaks, strictures, emptying, reflux, chylothorax. J Thorac Dis (2014) 0.79
Incidence and management of chylothorax after esophagectomy. Thorac Cancer (2015) 0.78
Thoracic duct injury following esophagectomy in carcinoma of the esophagus: ligation by the abdominal approach. World J Surg (2013) 0.77
Nutritional management in patients with chyle leakage: a systematic review. Eur J Clin Nutr (2015) 0.75
Ultrasound-guided intranodal lipiodol lymphangiography from the groin is useful for assessment and treatment of post-esophagectomy chylothorax in three cases. Int J Surg Case Rep (2016) 0.75
Common complications of nonvascular percutaneous thoracic interventions: diagnosis and management. Semin Intervent Radiol (2015) 0.75
Postesophagectomy chylothorax and esophageal squamous cell cancer: missing link? Ann Thorac Surg (2012) 0.75
Chyle leakage patterns and management after oncologic esophagectomy: A retrospective cohort study. Thorac Cancer (2014) 0.75
Localization of thoracic duct using heavily T2W MRI for intractable post-esophagectomy chylothorax-a case report. J Thorac Dis (2017) 0.75
Prophylaxis of chylothorax after esophagectomy. Ann Thorac Surg (2012) 0.75
Etiological approach of chylothorax in Babol, northern Iran. Caspian J Intern Med (2017) 0.75
Anatomic and Functional Evaluation of Central Lymphatics With Noninvasive Magnetic Resonance Lymphangiography. Medicine (Baltimore) (2016) 0.75
Chyluria after ligation of the thoracic duct: a rare complication after thoracoscopic-assisted esophagectomy for esophageal cancer. Surg Today (2012) 0.75
Transhiatal esophagectomy: clinical experience and refinements. Ann Surg (1999) 3.24
Management of thoracic duct injuries after oesophagectomy. Br J Surg (2001) 2.51
Chylothorax. Br J Surg (1997) 2.29
Postoperative chylothorax. J Thorac Cardiovasc Surg (1996) 2.19
Chylothorax complicating esophagectomy for cancer: a plea for early thoracic duct ligation. J Thorac Cardiovasc Surg (2000) 2.12
THE MANAGEMENT OF CHYLOTHORAX. Ann Surg (1964) 1.96
Diagnosis and treatment of postoperative chyle leakage via percutaneous transabdominal catheterization of the cisterna chyli: a preliminary study. J Vasc Interv Radiol (1998) 1.79
Nonoperative thoracic duct embolization for traumatic thoracic duct leak: experience in 109 patients. J Thorac Cardiovasc Surg (2009) 1.63
Chylothorax: an assessment of current surgical management. J Thorac Cardiovasc Surg (1985) 1.62
Chylothorax in cirrhosis of the liver: analysis of its frequency and clinical characteristics. Chest (1998) 1.46
Management of chylothorax by percutaneous catheterization and embolization of the thoracic duct: prospective trial. J Vasc Interv Radiol (1999) 1.37
Output of chyle as an indicator of treatment for chylothorax complicating oesophagectomy. Br J Surg (1998) 1.32
Thoracic duct injury during esophagectomy: 20 years experience at a tertiary care center in a developing country. Dis Esophagus (2004) 1.18
Aggressive treatment of chylothorax complicating transhiatal esophagectomy without thoracotomy. Surgery (1988) 1.11
Management of chylothorax complicating extensive esophageal resection. Surg Gynecol Obstet (1992) 1.02
Treatment of chylothorax: percutaneous catheterization and embolization of the thoracic duct. AJR Am J Roentgenol (2001) 1.01
Prophylactic thoracic duct mass ligation prevents chylothorax after transthoracic esophagectomy for cancer. World J Surg (2009) 0.98
Reexploration for complications after esophagectomy for cancer. J Thorac Cardiovasc Surg (1989) 0.89
Oesophageal carcinoma. Lancet (2013) 5.48
Esophageal sphincter device for gastroesophageal reflux disease. N Engl J Med (2013) 5.41
Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial. J Thorac Cardiovasc Surg (2011) 5.14
Outcomes after minimally invasive esophagectomy: review of over 1000 patients. Ann Surg (2012) 4.70
Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nat Genet (2013) 4.48
Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg (2003) 4.30
The Pittsburgh Lung Screening Study (PLuSS): outcomes within 3 years of a first computed tomography scan. Am J Respir Crit Care Med (2008) 4.22
Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg (2006) 3.76
Technology for automated, rapid, and quantitative PCR or reverse transcription-PCR clinical testing. Clin Chem (2005) 3.42
Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics. Clin Chem (2004) 2.90
MicroRNA expression profiles of esophageal cancer. J Thorac Cardiovasc Surg (2007) 2.85
Egr-1 regulates autophagy in cigarette smoke-induced chronic obstructive pulmonary disease. PLoS One (2008) 2.67
Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen. Cancer Res (2002) 2.52
Anatomic segmentectomy in the treatment of stage I non-small cell lung cancer. Ann Thorac Surg (2007) 2.48
Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis. Cancer Res (2012) 2.26
Hyperoxia-induced NAD(P)H oxidase activation and regulation by MAP kinases in human lung endothelial cells. Am J Physiol Lung Cell Mol Physiol (2002) 2.18
Anatomic segmentectomy for the solitary pulmonary nodule and early-stage lung cancer. Ann Thorac Surg (2012) 2.14
Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis. Ann Thorac Surg (2006) 2.12
Radiofrequency ablation of pulmonary malignant tumors in nonsurgical candidates. J Thorac Cardiovasc Surg (2003) 2.04
Survival after lung volume reduction in chronic obstructive pulmonary disease: insights from small airway pathology. Am J Respir Crit Care Med (2007) 2.04
Segmental resection spares pulmonary function in patients with stage I lung cancer. Ann Thorac Surg (2004) 1.93
Occult metastases in lymph nodes predict survival in resectable non-small-cell lung cancer: report of the ACOSOG Z0040 trial. J Clin Oncol (2011) 1.93
Minimally invasive operation for esophageal diverticula. Ann Thorac Surg (2005) 1.90
Results of laparoscopic repair of giant paraesophageal hernias: 200 consecutive patients. Ann Thorac Surg (2002) 1.89
Thymic carcinoma: a multivariate analysis of factors predictive of survival in 290 patients. Ann Thorac Surg (2012) 1.86
Outcomes after a decade of laparoscopic giant paraesophageal hernia repair. J Thorac Cardiovasc Surg (2009) 1.75
Esophagectomy for T1 esophageal cancer: outcomes in 100 patients and implications for endoscopic therapy. Ann Thorac Surg (2009) 1.68
Minimally invasive esophagectomy: results of a prospective phase II multicenter trial-the eastern cooperative oncology group (E2202) study. Ann Surg (2015) 1.67
Role of Nox4 and Nox2 in hyperoxia-induced reactive oxygen species generation and migration of human lung endothelial cells. Antioxid Redox Signal (2009) 1.64
Cervical pharyngostomy: an old technique revisited. Ann Surg (2008) 1.63
Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancer. Nucleic Acids Res (2008) 1.63
The laparoscopic approach to paraesophageal hernia repair. J Gastrointest Surg (2011) 1.62
Margin and local recurrence after sublobar resection of non-small cell lung cancer. Ann Surg Oncol (2007) 1.60
Resection for esophageal cancer: strategies for optimal management. Ann Thorac Surg (2008) 1.60
Surgical resection should be considered for stage I and II small cell carcinoma of the lung. Ann Thorac Surg (2012) 1.60
Thirty- and ninety-day outcomes after sublobar resection with and without brachytherapy for non-small cell lung cancer: results from a multicenter phase III study. J Thorac Cardiovasc Surg (2011) 1.59
Hydrogen preconditioning during ex vivo lung perfusion improves the quality of lung grafts in rats. Transplantation (2014) 1.51
Thymomas and extrathymic cancers. Ann Thorac Surg (2011) 1.48
Downregulation of Dkk3 activates beta-catenin/TCF-4 signaling in lung cancer. Carcinogenesis (2007) 1.46
Feasibility, safety, acceptability, and yield of office-based, screening transnasal esophagoscopy (with video). Gastrointest Endosc (2012) 1.46
Should endobronchial ultrasonography be part of the thoracic surgeon's armamentarium? J Thorac Cardiovasc Surg (2009) 1.45
Revisional surgery after esophagectomy: an analysis of 43 patients. Ann Thorac Surg (2008) 1.44
An extracellular matrix scaffold for esophageal stricture prevention after circumferential EMR. Gastrointest Endosc (2008) 1.43
Clinical significance of radiologic characterizations in COPD. COPD (2009) 1.41
Contemporaneous management of esophageal perforation. Surgery (2009) 1.41
Comparison of surgical techniques for early-stage thymoma: feasibility of minimally invasive thymectomy and comparison with open resection. J Thorac Cardiovasc Surg (2011) 1.41
Anterior minithoracotomy: a direct approach to the difficult hilum for upper lobectomy, pneumonectomy, and sleeve lobectomy. Ann Surg Oncol (2009) 1.38
Endobronchial ultrasound as a diagnostic tool in patients with mediastinal lymphadenopathy. Ann Thorac Surg (2009) 1.37
Regenerative therapy and cancer: in vitro and in vivo studies of the interaction between adipose-derived stem cells and breast cancer cells from clinical isolates. Tissue Eng Part A (2010) 1.37